Tesla to Make Molecule Printers for German COVID-19 Vaccine Developer CureVac

Tesla to Make Molecule Printers for German COVID-19 Vaccine Developer CureVac

Tesla is building mobile molecule printers in Germany to help create a potential COVID-19 vaccine being developed by CureVac, Elon Musk, the electric-car manufacturer’s chief executive, tweeted on Wednesday.

CureVac, a non-German company, has stated that it is developing portable, automated mRNA production units that it calls printers and which Musk describes as “RNA micro-factories”.

Also Read: Motorola Razr 5G tipped to come with 6.2 inch flexible display.

They are being designed to be shipped to remote locations, where they can brainstorm its vaccine candidates and other mRNA-based therapies based on the recipe fed into the machine.

But for immediate epidemic use – should its vaccine candidate get market approval – it has production sites in Germany with regulatory approvals that have the potential to produce hundreds of millions of doses.

Also Read: Amazfit zenbuds TWS earbuds with 12 hour battery life launched.

The company, based in Tuebingen and supported by the Bill & Melinda Gates Foundation, is a pioneer of the so-called Messenger RNA approach, which BioNTech and its partner Pfizer follow as well as Modern.

Follow iCvsTech on Facebook and Twitter. For the latest newstech news, breaking news headlines and live updates checkout icvstech.com